Last reviewed · How we verify

NCT03408704: ASP-Throat

Antimicrobial Stewardship Program (ASP) in Patients With a Sore Throat

Completed NA Last updated 6 June 2022
What this trial tests

NA trial testing ASP in Tonsillitis in 49 participants. Completed in 28 February 2022.

Timeline
17 January 2018
Primary endpoint
28 February 2022
28 February 2022

Quick facts

Lead sponsorVastra Gotaland Region
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposehealth services research
Enrollment49
Start date17 January 2018
Primary completion28 February 2022
Estimated completion28 February 2022
Sites1 location across Sweden

Drugs / interventions tested

Conditions studied

Sponsor

Vastra Gotaland Region — full company profile →

Who can join

Eligibility, any sex, with Tonsillitis or Streptococcus Pharyngitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The investigators have developed an antibiotic stewardship program (ASP) to increase adherence to the Swedish guidelines for managing patients with a sore throat. This is a randomized controlled trial where primary health care centers are randomised to get the ASP or not. The adherence to the Swedish guidelines are measured in all participating centers.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Tonsillitis

Currently open trials in the same condition.

Other Vastra Gotaland Region trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03408704.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing